Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 16;141(24):1948-1950.
doi: 10.1161/CIRCULATIONAHA.120.047122. Epub 2020 Apr 13.

Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?

Matthew J Daniels  1   2   3 , Mauricio G Cohen  4 , Anthony A Bavry  5 , Dharam J Kumbhani  5
Affiliations
Review

Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?

Matthew J Daniels et al. Circulation. .
No abstract available

Keywords: COVID-19; ST elevation myocardial infarction; percutaneous coronary intervention.

PubMed Disclaimer

Figures

Figure.
Figure.
Proposed STEMI reperfusion algorithm for coronavirus 2019 (COVID-19)–positive/presumed positive patients. Contraindications to fibrinolytic therapy as listed in 2013 American Heart Association/American College of Cardiology STEMI guidelines. ACE indicates angiotensin converting enzyme; CCL, cardiac catheterization laboratory; CV, cardiovascular; IRA, infarct related artery; PCI, percutaneous coronary intervention; PI, pharmacoinvasive strategy; PUI, person under investigation; STE, ST-elevation; and STEMI, ST-elevation myocardial infarction.
See this image and copyright information in PMC

References

    1. Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D, Chen AY, Klein LW, Masoudi FA, McKay C, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010;56:254–263. doi: 10.1016/j.jacc.2010.05.008. - PubMed
    1. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Rosell Ortiz F, Ostojic M, Welsh RC, et al. STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013;368:1379–1387. doi: 10.1056/NEJMoa1301092. - PubMed
    1. Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M, Lam YM, Chan C, Tsang TC, Tsui M, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020;13:e006631. doi: 10.1161/CIRCOUTCOMES.120.006631. - PMC - PubMed
    1. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol. 2003;92:824–826. doi: 10.1016/s0002-9149(03)00891-9. - PubMed
    1. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382:1564–1567. doi: 10.1056/NEJMc2004973. - PMC - PubMed

MeSH terms

Substances